Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.

BACKGROUND: Prion diseases are a group of invariably fatal neurodegenerative disorders affecting humans and a wide range of mammals. An essential part of the infectious agent, termed the prion, is composed of an abnormal isoform (PrP(Sc)) of a host-encoded normal cellular protein (PrP(C)). The conve...

Full description

Bibliographic Details
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2005-12-01
Series:PLoS Medicine
Online Access:http://dx.doi.org/10.1371/journal.pmed.0030014
id doaj-d63eb2872e3a494f8ee70b7db63c51b3
record_format Article
spelling doaj-d63eb2872e3a494f8ee70b7db63c51b32020-11-24T23:33:13ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762005-12-0132e14Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.BACKGROUND: Prion diseases are a group of invariably fatal neurodegenerative disorders affecting humans and a wide range of mammals. An essential part of the infectious agent, termed the prion, is composed of an abnormal isoform (PrP(Sc)) of a host-encoded normal cellular protein (PrP(C)). The conversion of PrP(C) to PrP(Sc) is thought to play a crucial role in the development of prion diseases and leads to PrP(Sc) deposition, mainly in the central nervous system. Sporadic Creutzfeldt-Jakob disease (sCJD), the most common form of human prion disease, presents with a marked clinical heterogeneity. This diversity is accompanied by a molecular signature which can be defined by histological, biochemical, and genetic means. The molecular classification of sCJD is an important tool to aid in the understanding of underlying disease mechanisms and the development of therapy protocols. Comparability of classifications is hampered by disparity of applied methods and inter-observer variability. METHODS AND FINDINGS: To overcome these difficulties, we developed a new quantification protocol for PrP(Sc) by using internal standards on each Western blot, which allows for generation and direct comparison of individual PrP(Sc) profiles. By studying PrP(Sc) profiles and PrP(Sc) type expression within nine defined central nervous system areas of 50 patients with sCJD, we were able to show distinct PrP(Sc) distribution patterns in diverse subtypes of sCJD. Furthermore, we were able to demonstrate the co-existence of more than one PrP(Sc) type in individuals with sCJD in about 20% of all patients and in more than 50% of patients heterozygous for a polymorphism on codon 129 of the gene encoding the prion protein (PRNP). <br>CONCLUSION: PrP(Sc) profiling represents a valuable tool for the molecular classification of human prion diseases and has important implications for their diagnosis by brain biopsy. Our results show that the co-existence of more than one PrP(Sc) type might be influenced by genetic and brain region-specific determinants. These findings provide valuable insights into the generation of distinct PrP(Sc) types.http://dx.doi.org/10.1371/journal.pmed.0030014
collection DOAJ
language English
format Article
sources DOAJ
title Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.
spellingShingle Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.
PLoS Medicine
title_short Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.
title_full Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.
title_fullStr Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.
title_full_unstemmed Analysis of Prion Strains by PrP(Sc) Profiling in Sporadic Creutzfeldt-Jakob Disease.
title_sort analysis of prion strains by prp(sc) profiling in sporadic creutzfeldt-jakob disease.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2005-12-01
description BACKGROUND: Prion diseases are a group of invariably fatal neurodegenerative disorders affecting humans and a wide range of mammals. An essential part of the infectious agent, termed the prion, is composed of an abnormal isoform (PrP(Sc)) of a host-encoded normal cellular protein (PrP(C)). The conversion of PrP(C) to PrP(Sc) is thought to play a crucial role in the development of prion diseases and leads to PrP(Sc) deposition, mainly in the central nervous system. Sporadic Creutzfeldt-Jakob disease (sCJD), the most common form of human prion disease, presents with a marked clinical heterogeneity. This diversity is accompanied by a molecular signature which can be defined by histological, biochemical, and genetic means. The molecular classification of sCJD is an important tool to aid in the understanding of underlying disease mechanisms and the development of therapy protocols. Comparability of classifications is hampered by disparity of applied methods and inter-observer variability. METHODS AND FINDINGS: To overcome these difficulties, we developed a new quantification protocol for PrP(Sc) by using internal standards on each Western blot, which allows for generation and direct comparison of individual PrP(Sc) profiles. By studying PrP(Sc) profiles and PrP(Sc) type expression within nine defined central nervous system areas of 50 patients with sCJD, we were able to show distinct PrP(Sc) distribution patterns in diverse subtypes of sCJD. Furthermore, we were able to demonstrate the co-existence of more than one PrP(Sc) type in individuals with sCJD in about 20% of all patients and in more than 50% of patients heterozygous for a polymorphism on codon 129 of the gene encoding the prion protein (PRNP). <br>CONCLUSION: PrP(Sc) profiling represents a valuable tool for the molecular classification of human prion diseases and has important implications for their diagnosis by brain biopsy. Our results show that the co-existence of more than one PrP(Sc) type might be influenced by genetic and brain region-specific determinants. These findings provide valuable insights into the generation of distinct PrP(Sc) types.
url http://dx.doi.org/10.1371/journal.pmed.0030014
_version_ 1725531608475238400